Private Capital Group’s Bio-Techne TECH Stock Holding History

Private Capital Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$19K	Hold	216	–	–	0.01%	857
2022 Q1	$23K	Sell	216 -96	-31%	-$9.9K	0.01%	976
2021 Q4	$40K	Hold	312	–	–	0.01%	788
2021 Q3	$38K	Hold	312	–	–	0.01%	797
2021 Q2	$35K	Hold	312	–	–	0.01%	821
2021 Q1	$30K	Buy	312 +228	+271%	+$20.8K	0.01%	856
2020 Q4	$7K	Sell	84 -228	-73%	-$16.5K	﹤0.01%	1496
2020 Q3	$19K	Hold	312	–	–	﹤0.01%	1115
2020 Q2	$21K	Sell	312 -100	-24%	-$5.99K	﹤0.01%	1089
2020 Q1	$20K	Buy	+412	New	+$20.6K	0.01%	1017

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Private Capital Group's TECH Position: Q2 2022 in Review

Private Capital Group held its Bio-Techne (TECH) position steady in Q2 2022 at 216 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #857.

Private Capital Group first reported a position in TECH in Q1 2020 and has held it in 10 quarters since. The position peaked at $40K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

Private Capital Group held 216 shares of Bio-Techne worth $19K as of Q2 2022.
Private Capital Group left its Bio-Techne share count unchanged in Q2 2022.
Bio-Techne made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #857 holding.
Private Capital Group first reported a position in Bio-Techne in Q1 2020 and has held it in 10 quarters since.
Private Capital Group's Bio-Techne position peaked at $40K in Q4 2021.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.